u.s. senate passes h.r. 3204 and sends it to president obama. bill would preempt all current serialization and pedigree laws, have impact on compounding. dqsa will also give the u.s. food and drug administration greater authority to regulate companies that compound sterile drugs and ship them across state lines. the legislation draws a distinction between traditional compounding pharmacies, which will continue to be regulated by state boards of pharmacy . bill still lying on presidents table for final signature.